Effects of topiramate on oral dyskinesia induced by reserpine

Brain Research Bulletin

Volumn 64, Issue 4, 2004, Pages 331-337

  Araujo, Nilza P ^a   Abílio, Vanessa C ^a   Silva, Regina H ^a   Pereira, Renata C ^a   Carvalho, Rita C ^a   Gonzalez, Carla ^a   Bellot, Rogério G ^a   Castro, Juliana P M V ^a   Fukushiro, Daniela F ^a   Rodrigues, Marcelo S D ^a   Chinen, Cibele C ^a   Frussa Filho, Roberto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anticonvulsant; GABA; Mice; Movement disorders

Indexed keywords

RESERPINE; TOPIRAMATE;

ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DYSKINESIA; FEMALE; LOCOMOTION; MOUSE; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; FEMALE; FRUCTOSE; LOCOMOTION; MASTICATION; MATERNAL BEHAVIOR; MICE; NEUROPROTECTIVE AGENTS; RESERPINE;

EID: 9244235513     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2004.09.001     Document Type: Article

References (54)

1. V.C. Abílio, C.C.S. Araujo, M. Bergamo, P.R.V. Calvente, V. D'Almeida, R.A. de Ribeiro, and R. Frussa-Filho Vitamin E attenuates reserpine-induced oral dyskinesia and striatal gssg/gsh ratio enhancement in rats Prog. Neuropsychopharmacol. Biol. Psychiatry 27 2003 109 114
2. V.C. Abílio, R.H. Silva, R.C. Carvalho, C. Grassl, M.B. Calzavara, S. Registro, V. D'Almeida, R.A. de Ribeiro, and R. Frussa-Filho Important role of striatal catalase in aging- and reserpine-induced oral dyskinesia Neuropharmacology 47 2004 263 272
3. V.C. Abílio, J.A.R. Vera Jr., L.S.M. Ferreira, C.R.M. Duarte, R.C. Carvalho, C. Grassl, C.R. Martins, D. Torres-Leite, M. Bignotto, S. Tufik, R.A. de Ribeiro, and R. Frussa-Filho Effects of melatonin on orofacial movements in rats Psychopharmacology 161 2002 340 347
4. S. Ahlenius, V. Hillegaart, G. Thorell, O. Magnusson, and C.J. Fowler Suppression of exploratory locomotor activity and increase in dopamine turnover following the application of cis-flupenthixol into limbic projection areas of the rat striatum Brain Res. 402 1987 131 138
5. I.M.H. Al-Khatib, I. Dökmeci, and M. Fujiwara Differential role of nucleus accumbens and caudate-putamen in mediating the effect of nomifensine and methamphetamine on ambulation and rearing of rats in the open-field test Jpn. J. Pharmacol. 67 1995 69 77
6. J. Ananth, A. Djenderedjian, M. Beshay, M. Kamal, A. Kodijan, and C. Barriga Baclofen in the treatment of tardive dyskinesia Curr. Ther. Res. 42 1987 111 114
7. O.A. Andreassen, and H.A. Jorgesen Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats: implications for tardive dyskinesia? Prog. Neurobiol. 61 2000 525 541
8. M. Angehagen, E. Bem-Menachem, L. Ronnback, and E. Hansson Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate Neurochem. Res. 28 2 2003 333 340
9. P. Baskin, and J. Salamone Vacuous jaw movements in rats induced by acute reserpine administration: interactions with different doses of apomorphine Pharmacol. Biochem. Behav. 46 4 1993 793 797
10. M. Bergamo, V.C. Abílio, C.M.T. Queiroz, H.N. Barbosa- Júnior, L.R.A. Abdanur, and R. Frussa-Filho Effects of age on a new animal model of tardive dyskinesia Neurobiol. Aging 18 1997 623 629
11. E. Brouillet, F. Conde, M.F. Beal, and P. Hantraye Replicating Huntington's disease phenotype in experimental animals Prog. Neurobiol. 59 1999 427 468
12. M.E. Burger, A. Alvis, L. Callegari, F.R. Athayde, C.W. Nogueira, G. Zeni, and J.B. Rocha Ebselen attenuates reserpine-induced orofacial dyskinesia and oxidative stress in rat striatum Prog. Neuropsychopharmacol. Biol. Psychiatry 27 1 2003 135 140
13. P.R.V. Calvente, C.C.S. Araujo, M. Bergamo, V.C. Abílio, V. D'Almeida, R.A. de Ribeiro, and R. Frussa-Filho The motochondrial toxin 3-nitropropionic acid aggravates reserpine-induced oral dyskinesia in rats Prog. Neuropsychopharmacol. Biol. Psychiatry 26 2002 1 5
14. R.C. Carvalho, R.H. Silva, V.C. Abílio, P.N. Barbosa, and R. Frussa-Filho Antydiskinetic effects of risperidone on animal models of tardive dyskinesia in mice Brain Res. Bull. 60 2003 115 124
15. S.L. Cassady, G.K. Thaker, and C.A. Tamminga GABAergic treatments for tardive dyskinesia R. Yassa P.V. Nair D.P. Jeste Neuroleptic-induced Movements Disorders 1997 Cambridge University Press New York 454 469
16. I. Creese, and S.D. Iversen The pharmacological and anatomical substrates of the amphetamine response in the rat Brain Res. 83 1975 419 436
17. A.M. Donaire, and D. Gil-Saladie Progressive primary aphasia associated with corticobasal degeneration Rev. Neurol. 32 11 2001 1051 1054
18. R.C. Dutra, A.P. Andreazza, R. Andreatini, S. Tufik, and A.B.F.M. Vital Behavioral effects of MK-801 on reserpine-treated mice Prog. Neuropsychopharmacol. Biol. Psychiatry 26 2002 487 495
19. R. Frussa-Filho, and J. Palermo-Neto Effects of single and long-term metoclopramide administration on open-field and stereotyped behavior of rats Eur. J. Pharmacol. 149 1988 323 329
20. L.B. Gerding, and L.A. Labatte Use of clonazepam in an elderly bipolar patient with tardive dyskinesia: a case report Ann. Clin. Psychiatry 11 2 1999 87 89
21. J. Gerlach, and D.E. Casey Tardive dyskinesia Acta Psychiatr. Scand. 77 1988 369 378
22. L.M. Gunne, U. Anderson, U. Bondesson, and P. Johanson Spontaneous chewing movements in rats during acute and chronic antipsychotic administration Pharmacol. Biochem. Behav. 25 1986 897 901
23. L.M. Gunne, J.E. Haggstrom, and B. Sjokvist Association with persistent neuroleptic-induced dyskinesia of regional changes in the brain GABA synthesis Nature 309 1984 347 349
24. M.H. Izaldin, I. Dökmeci, and M. Fujiwara Differential role of nucleus accumbens and caudate-putamen in mediating the effect of nomifensine and methanphetamine on ambulation and rearing of rats in the open-field test Jpn. J. Pharmacol. 67 1995 69 77
25. D.M. Jackson, N.-E. Andén, and A. Dahlström A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain Psychopharmacologia 45 1975 139 149
26. G.A. Jicha, and J.D. Salamone Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms J. Neurosci. 11 12 1991 3822 3829
27. P.H. Kelly, P.W. Seviour, and S.D. Iversen Amphetamine and apomorphine responses in the rat following 6-OHDA lesion of the nucleus accumbens, septi and corpus striatum Brain Res. 94 1975 507 522
28. H.L. Klawans The pharmacology of tardive dyskinesia Am. J. Psychiatry 130 1973 82 86
29. P.-M. Llorca, I. Chereau, F.-J. Bayle, and C. Lancon Tardive dyskinesia and antipsychotics: a review Eur. Psychiatry 17 2002 129 138
30. J.L. Neisewander, E. Castañeda, and D.A. Davis Dose-dependent differences in the development of reserpine-induced oral dyskinesia in rats: support for a model of tardive dyskinesia Psychopharmacology 116 1994 79 84
31. J.L. Neisewander, E. Castañeda, D.A. Davis, H.J. Elson, and A.N. Sussman Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia Eur. J. Pharmacol. 305 1-3 1996 13 21
32. J.L. Neisewander, I. Lucki, and P. Mcgonigle Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats J. Pharmacol. Exp. Ther. 257 1991 850 860
33. J.L. Neisewander, I. Lucki, and P. Mcgonigle Neurochemical changes associated with the persistence of spontaneous oral dyskinesia in rats following chronic reserpine treatment Brain Res. 558 1991 27 35
34. V. Paille, P. Brachet, and P. Damier Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease NeuroReport 15 3 2004 561 564
35. J. Palermo-Neto, and R. Frussa-Filho Behavioural models of tardive dyskinesia in rodents: a chronological review C.L. Bolis J. Licino Dopaminergic System: Its Evolution from Biology to Clinical Aspects 2001 AIREN (International Association for Research and Training in Neurosciences) and World Health Organization Geneva 61 81
36. M.F. Peixoto, V.C. Abílio, R.H. Silva, and R. Frussa-Filho Effects of valproic acid on an animal model of tardive dyskinesia Behav. Brain Res. 142 2003 229 233
37. C.M.T. Queiroz, and R. Frussa-Filho Effects of buspirone on an animal model of tardive dyskinesia Prog. Neuropsychopharmacol. Biol. Psychiatry 23 1999 1405 1418
38. V. Raghavendra, P.S. Naidu, and S.K. Kulkarni Reversal of reserpine-induced vacuous chewing movements in rats by melatonin: involvement of peripheral benzodiazepine receptors Brain Res. 904 2001 149 152
39. J. Romwell, H.M. Fernandez, and M.S. Okun Rationale for current therapies in Parkinson's disease Expert Opin. Pharmacother. 4 10 2003 1747 1761
40. O.S. Sachdev The current status of tardive dyskinesia Aust. N. Z. J. Psychiatry 34 2000 355 369
41. J.D. Salamone, and P. Baskin Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible mode of parkinsonian tremor Pharmacol. Biochem. Behav. 53 1 1996 179 183
42. T. Sasaki, J.L. Kennedy, and J.N. Nobrega Localized changes in GABA receptor-gated chloride channel in rat brain after long-term haloperidol: relation to vacuous chewing movements Synapse 25 1997 73 79
43. A. Senkowska, and K. Ossowska Role of metabotropic glutamate receptors in animal models of Parkinson's disease Pol. J. Pharmacol. 55 2003 935 950
44. R.P. Shank, J.F. Gardocki, and J.L. Vaught Topiramate: preclinical evaluation of a structurally novel anticonvulsant Epilepsia 35 1994 450 460
45. K.V.S. Soares, J.J. McGrath, J.J. Deeks, Gamma-aminobityric acid agonists for neuroleptic-induced tardive dyskinesia (Cochrane Review), In: The Cochrane Library, issue 1, Oxford, 2001.
46. R.E. Steinpreis, P. Baskin, and J.D. Salamone Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine Psychopharmacology 111 1993 99 105
47. A.N. Sussman, L.T.L. Tran-Nguyen, and J.L. Neisewander Acute reserpine administration elicits long-term spontaneous oral dyskinesia Eur. Pharmacol. 337 1997 157 160
48. G.K. Thaker, J.A. Nguyen, M.E. Stauss, R. Jacobson, B.A. Kaup, and C.A. Tamminga Clonazepam treatment of tardive dyskinesia: a pratical GABAmimetic strategy Am. J. Psychiatry 147 1990 445 451
49. G.K. Thaker, A.J. Nguyen, and C.A. Tamminga Increased saccadic distractibility in tardive dyskinesia: functional evidence for subcortical GABA dysfunction Biol. Psychiatry 1 1988 49 59
50. G.K. Thaker, C.A. Tamminga, L.D. Alphs, J. Lafferman, T.N. Ferraro, and T.A. Hare Brain gamma-aminobutyric acid abnormality in tardive dyskinesia Arc. Gen. Psychiatry 44 1987 522 529
51. H.S. White, S.D. Brown, G.A. Skeen, H.H. Wolf, and R.E. Twyman The anticonvulsivant topiramate displays a unique ability to potentiate GABA-evoked chloride currents Epilepsia 36 1997 S39 S40
52. H.S. White, S.D. Brown, J.H. Woodhead, G.A. Skeen, and H.H. Wolf Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold Epilepsy Res. 28 1997 167 179
53. S. Wolfarth, and K. Ossowska Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia? Prog. Neuropsychopharmacol. Biol. Psychiatry 13 1989 799 840
54. I. Wonodi, H. Adami, J. Sherr, M. Avila, L.E. Hong, and G.K. Thaker Naltrexone treatment of tardive dyskinesia in patients with schizophrenia Clin. Psychopharmacol. 24 4 2004 441 445